Target intelligence / Profile preview

Calcium voltage-gated channel subunit alpha1 C pre-mRNA exon 8A region (CACNA1C exon 8A)

Target
CACNA1C exon 8A
Molecular classification
Pre-mRNA, RNA regulatory element
01

Overview

The Calcium voltage-gated channel subunit alpha1 C (CACNA1C) pre-mRNA exon 8A region is a critical regulatory segment of the gene encoding the pore-forming subunit of the Cav1.2 L-type calcium channel (Splawski et al., 2004). This region undergoes mutually exclusive splicing with exon 8, where exon 8A is the predominant isoform in the heart and brain during early development (Diebold et al., 2002). A specific G406R mutation within exon 8A leads to Timothy Syndrome, a multi-system disorder characterized by lethal cardiac arrhythmias and autism spectrum phenotypes due to impaired channel inactivation (Splawski et al., 2004). Therapeutic targeting of this pre-mRNA region utilizes antisense oligonucleotides (ASOs) to modulate splicing, effectively switching the expression from the mutated exon 8A to the functional, wild-type exon 8 (Song et al., 2024). This splice-switching approach aims to restore normal electrophysiological properties in affected tissues like the myocardium and neurons (Panagiotakos et al., 2015).

Other names
CACNA1C exon 8.1Cav1.2 exon 8ATimothy Syndrome mutation locusCACNA1C alternative exon 8
02

Mechanism of action

Splicing modulation to induce exon skipping of the mutated exon 8A and promote inclusion of the alternative wild-type exon 8 (Song et al., 2024).

03

Biological functions

Alternative splicingCalcium ion transport regulationElectrophysiological signalingCardiac action potential modulationNeuronal excitability
04

Disease associations

Timothy SyndromeLong QT Syndrome type 8Autism spectrum disorderBipolar disorderSchizophrenia
05

Safety considerations

Off-target splicing of other CACNA1C exonsSystemic calcium channel blockade leading to hypotensionPotential neurotoxicity from intrathecal ASO deliveryIncomplete restoration of wild-type channel function
06

Interacting drugs

Antisense oligonucleotides (ASOs)

1 more in the full profile.

07

Biomarkers

Exon 8A to Exon 8 mRNA ratioQT interval duration (ECG)Calcium current inactivation kinetics

Beyond the preview

Go deeper on Calcium voltage-gated channel subunit alpha1 C pre-mRNA exon 8A region (CACNA1C exon 8A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium voltage-gated channel subunit alpha1 C pre-mRNA exon 8A region (CACNA1C exon 8A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call